• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

司来吉兰和去甲基司来吉兰可保护中脑神经元免受谷胱甘肽耗竭诱导的毒性作用。

Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.

作者信息

Mytilineou C, Leonardi E K, Radcliffe P, Heinonen E H, Han S K, Werner P, Cohen G, Olanow C W

机构信息

Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029, USA.

出版信息

J Pharmacol Exp Ther. 1998 Feb;284(2):700-6.

PMID:9454817
Abstract

Oxidative stress is thought to play an important role in the pathogenesis of Parkinson's disease (PD). Glutathione (GSH), a major cellular antioxidant, is decreased in the substantia nigra pars compacta of PD patients. The aim of the present study was to investigate whether deprenyl and its desmethyl metabolite, putative neuroprotective agents in the treatment of PD, could protect cultured rat mesencephalic neurons from cell death caused by GSH depletion due to treatment with L-buthionine-(S,R)-sulfoximine (BSO). BSO (10 microM) caused extensive cell death after 48 hr, as demonstrated by disruption of cellular integrity and release of lactate dehydrogenase into the culture medium. Both deprenyl and desmethylselegiline, at concentrations of 5 and 50 microM, significantly protected dopaminergic neurons from toxicity without preventing the BSO-induced loss in GSH. Protection was not associated with monoamine oxidase type B inhibition in that pargyline, a potent MAO inhibitor, was ineffective and pretreatment with pargyline did not prevent the protective effects of deprenyl. Protection was not associated with inhibition of dopamine uptake by deprenyl because the dopamine uptake inhibitor mazindol did not diminish BSO toxicity. The antioxidant ascorbic acid (200 microM) also protected against BSO-induced cell death, suggesting that oxidative events were involved. This study demonstrates that deprenyl and its desmethyl metabolite can diminish cell death associated with GSH depletion.

摘要

氧化应激被认为在帕金森病(PD)的发病机制中起重要作用。谷胱甘肽(GSH)是一种主要的细胞抗氧化剂,在PD患者的黑质致密部中含量降低。本研究的目的是调查丙炔苯丙胺及其去甲基代谢产物(PD治疗中的假定神经保护剂)是否能保护培养的大鼠中脑神经元免受因L-丁硫氨酸-(S,R)-亚砜亚胺(BSO)处理导致的GSH耗竭所引起的细胞死亡。48小时后,10微摩尔的BSO导致广泛的细胞死亡,这可通过细胞完整性的破坏以及乳酸脱氢酶释放到培养基中得到证明。丙炔苯丙胺和去甲基司来吉兰在浓度为5和50微摩尔时,均能显著保护多巴胺能神经元免受毒性,且不会阻止BSO诱导的GSH损失。这种保护作用与B型单胺氧化酶抑制无关,因为有效的MAO抑制剂帕吉林无效,且用帕吉林预处理并不能阻止丙炔苯丙胺的保护作用。这种保护作用也与丙炔苯丙胺对多巴胺摄取的抑制无关,因为多巴胺摄取抑制剂吗吲哚并不能减轻BSO的毒性。抗氧化剂抗坏血酸(200微摩尔)也能保护细胞免受BSO诱导的细胞死亡,这表明氧化事件参与其中。本研究表明,丙炔苯丙胺及其去甲基代谢产物可减少与GSH耗竭相关的细胞死亡。

相似文献

1
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.司来吉兰和去甲基司来吉兰可保护中脑神经元免受谷胱甘肽耗竭诱导的毒性作用。
J Pharmacol Exp Ther. 1998 Feb;284(2):700-6.
2
L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.左旋司来吉兰可保护大鼠免受鱼藤酮诱导的、氧化应激介导的多巴胺能神经退行性变。
Neurochem Int. 2006 Jul;49(1):28-40. doi: 10.1016/j.neuint.2005.12.016. Epub 2006 Feb 21.
3
L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.左旋司来吉兰在体外可保护中脑多巴胺能神经元免受谷氨酸受体介导的毒性作用。
J Neurochem. 1997 Jan;68(1):33-9. doi: 10.1046/j.1471-4159.1997.68010033.x.
4
R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.R(-)-司来吉兰增强多巴胺对儿茶酚胺能神经母细胞瘤SH-SY5Y细胞的细胞毒性。
Toxicol Appl Pharmacol. 1997 Jan;142(1):186-91. doi: 10.1006/taap.1996.8011.
5
L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro.L-(-)-去甲基司来吉兰,司来吉兰[L-(-)-丙炔苯丙胺]的一种代谢产物,在体外可保护中脑多巴胺神经元免受兴奋性毒性作用。
J Neurochem. 1997 Jan;68(1):434-6. doi: 10.1046/j.1471-4159.1997.68010434.x.
6
Neurotoxicity from glutathione depletion is dependent on extracellular trace copper.谷胱甘肽耗竭引起的神经毒性取决于细胞外微量铜。
J Neurosci Res. 2003 Mar 15;71(6):889-97. doi: 10.1002/jnr.10537.
7
L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.L-司来吉兰无法保护中脑多巴胺能神经元和PC12细胞免受1-甲基-4-苯基吡啶离子的神经毒性作用。
Brain Res. 1996 Nov 25;741(1-2):68-74. doi: 10.1016/s0006-8993(96)00898-0.
8
Manganese neurotoxic time course is not influenced by L-deprenyl systemic treatment: influence of L-deprenyl in manganese neurotoxic time course.系统给予 L--deprenyl 并不影响锰的神经毒性时程:L- deprenyl 对锰的神经毒性时程的影响。
Brain Res. 2010 Mar 4;1317:277-85. doi: 10.1016/j.brainres.2009.12.066. Epub 2010 Jan 4.
9
Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation.司来吉兰是一种治疗帕金森病的药物,它通过抑制JNK激活来抑制因谷胱甘肽耗竭而增强的砷毒性。
J Toxicol Environ Health A. 2004 Dec;67(23-24):2013-24. doi: 10.1080/15287390490514732.
10
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B].[司来吉兰的历史——首个单胺氧化酶B型选择性抑制剂]
Vopr Med Khim. 1997 Nov-Dec;43(6):482-93.

引用本文的文献

1
Neuronal Responses to Ischemia: Scoping Review of Insights from Human-Derived In Vitro Models.神经元对缺血的反应:来自人源体外模型的见解的范围综述。
Cell Mol Neurobiol. 2023 Oct;43(7):3137-3160. doi: 10.1007/s10571-023-01368-y. Epub 2023 Jun 28.
2
90 years of monoamine oxidase: some progress and some confusion.90 年的单胺氧化酶:一些进展和一些困惑。
J Neural Transm (Vienna). 2018 Nov;125(11):1519-1551. doi: 10.1007/s00702-018-1881-5. Epub 2018 Apr 10.
3
Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system.
胡豆碱,一种内源性化合物,在中枢神经系统中引发两阶段的相反作用。
Neurotox Res. 2015 Apr;27(3):300-13. doi: 10.1007/s12640-014-9511-y. Epub 2014 Dec 24.
4
Concentration-dependent opposite effects of 1-benzyl-1,2,3,4-tetrahydroisoquinoline on markers of apoptosis: in vitro and ex vivo studies.浓度依赖性的 1-苄基-1,2,3,4-四氢异喹啉对细胞凋亡标志物的相反作用:体外和体内研究。
Neurotox Res. 2014 Jan;25(1):90-9. doi: 10.1007/s12640-013-9436-x. Epub 2013 Nov 5.
5
Beta-amyloidolysis and glutathione in Alzheimer's disease.阿尔茨海默病中的β-淀粉样蛋白分解与谷胱甘肽
J Blood Med. 2013 Apr 15;4:31-8. doi: 10.2147/JBM.S35496. Print 2013.
6
MAO-inhibitors in Parkinson's Disease.MAO 抑制剂在帕金森病中的应用。
Exp Neurobiol. 2011 Mar;20(1):1-17. doi: 10.5607/en.2011.20.1.1. Epub 2011 Mar 31.
7
Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease.神经病学争议:单胺氧化酶 B 抑制剂为何可能成为帕金森病初始治疗的优选药物。
BMC Neurol. 2011 Sep 22;11:112. doi: 10.1186/1471-2377-11-112.
8
Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.(-)丙炔苯丙胺、(-)去甲丙炔苯丙胺和(-)丙炔苯丙胺-N-氧化物对谷胱甘肽耗竭的 A-2058 黑素瘤细胞的细胞保护作用。
J Neural Transm (Vienna). 2010 Jun;117(6):695-8. doi: 10.1007/s00702-010-0413-8. Epub 2010 May 9.
9
Metabolism of N-methyl, N-propargylphenylethylamine: studies with human liver microsomes and cDNA expressed cytochrome P450 (CYP) enzymes.N-甲基-N-炔丙基苯乙胺的代谢:用人肝微粒体和cDNA表达的细胞色素P450(CYP)酶进行的研究。
Cell Mol Neurobiol. 2007 Mar;27(2):179-90. doi: 10.1007/s10571-006-9085-1. Epub 2006 Dec 8.
10
Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.帕金森病的神经保护策略:抵御自由基诱导的黑质进行性损伤
Neurotox Res. 2000;2(2-3):293-310. doi: 10.1007/BF03033799.